AstraZeneca could pay up to $6 billion to Japan's Daiichi Sankyo to develop and market a type of targeted cancer treatment in the second multi-billion dollar cancer drug collaboration between the two companies.
) to develop and market a type of targeted cancer treatment in the second multi-billion dollar cancer drug collaboration between the two companies.
The drugmakers signed a near $7 billion deal last year for a breast cancer treatment, now called Enhertu, which is being tested in other tumour types too.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
WSJ News Exclusive | Rush Street Interactive to Go Public as Part of a $1.8 Billion DealOnline sports-and-casino betting company Rush Street Interactive has agreed to go public via a merger with a blank-check company that will value the online sports-and-casino betting company at about $1.8 billion including debt
Weiterlesen »
Opinion | Stop fretting about Trump and do something about it. Right now.Opinion: Stop fretting about Trump and do something about it. Right now.
Weiterlesen »
Biden beefs up Hill outreach as campaign rides high in final months - POLITICODemocrats in both the House and Senate have seen a substantial uptick in outreach from the Biden campaign in recent weeks
Weiterlesen »
Ex-UCLA RB Craig Lee Cuts Deal In Attempted Murder Case, Gets ProbationThe ex-UCLA running back is breathing much easier after cutting a plea deal with prosecutors.
Weiterlesen »
Mary Kay Letourneau Still Married to Vili Fualaau When She DiedMary Kay Letourneau was cremated after losing her battle with colon cancer, according to her death certificate.
Weiterlesen »
Larry Hogan On The Parallels Of Fighting Cancer And Maryland's Coronavirus OutbreakNPR's Michel Martin speaks with Maryland Gov. Larry Hogan about his new book Still Standing: Surviving Cancer, Riots, a Global Pandemic, and the Toxic Politics That Divide America.
Weiterlesen »